Themis Medicare Ltd

Know More
NSEBSE

257.604.25 (1.68%)

12:00 AM,2nd Mar 2024

258.406.10 (2.42%)

12:00 AM,2nd Mar 2024

BSE : 530199

NSE : THEMISMED

Sector : Health care

ISIN Code : INE083B01024

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Mar 02 2024 | 12:00 AM IST

Market Cap (₹ Cr)

2369

Turnover (₹ Cr)

0.10

Volume (Shares)

39535

Face Value

1

52-WK High

263.85

52-WK High Date

02 Mar 2024

52-WK Low

109.64

52-WK Low Date

28 Mar 2023

All Time High

263.85

All Time High Date

02 Mar 2024

All Time Low

4.00

All Time Low Date

04 Sep 2013

Themis Medicare Ltd

Incorporated in 1969 Themis Medicare Ltd. formerly known as Themis Chemicals (TCL) was originally promoted by Chemosyn and Medimpex but was taken over by a group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics which was merged with Artemis Pharmaceuticals in April 93.In Mar.'95 the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi the setting up of a formulation unit at Lilora Baroda as backward integration and to augment long-term working capital.Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of anti-tuberculosis cerebroactivators bronchodilators anti-asthmatic anaesthetic and other segments.Anti-tuberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin an anti-bacterial drug for veterinary use for which it has a confirmed buy-back arrangement with Chinoin Hungary.The company with the help of M/s PharmogradMoscow a manufacturing unit is planning to market its Anti-T.B.formulation products through the collborators throughout the Russian Federation for tradetenders and govt.supplies.

Themis Medicare Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

2369

EPS - TTM (₹) [S]

3.01

P/E Ratio (X) [S]

9.02

Face Value (₹) 1
Latest Dividend (%)50.00
Latest Dividend Date 01 Sep 2023
Dividend Yield (%) 0.19
Book Value Share (₹) [S]28.56
P/B Ratio (₹) [S]9.02
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.01 322 0.08

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

253.35

263.85

Week Low/High

231.05

264.00

Month Low/High

194.00

264.00

Year Low/High

109.64

264.00

All time Low/High

1.20

264.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week7.74%7.92%0.910.75%
1 Month11.54%12.00%2.392.40%
3 Month50.56%50.51%9.3710.41%
6 Month62.07%61.45%12.8815.14%
1 Year113.83%113.39%25.2929.19%
3 Year738.00%739.91%46.7450.00%

Company Info

Company Information

Non-Exec & Non-Independent Dir : Rajneesh Anand

Independent Non Exe. Director : VIJAY GOPI KISHAN AGARWAL

Independent Non Exe. Director : Hari Subramaniam

Non Executive Director : Reena S Patel

ED / MD / CEO / Promoter : Sachin D Patel

Chairman & Independent Directo : Dinesh S Patel

Independent Non Exe. Director : Manjul Sandhu

Independent Non Exe. Director : Bhaskar Vemban Iyer

Additional Director : Shishir Dalal

Alternate Director : Reena S Patel

Registered Office: Plot No 69 A GIDC Indl Estate, Vapi,Valsad,Gujarat-396195 Ph: 91-260-2421675

Email:themis@themismedicare.com

URL:http://www.themismedicare.com